Humana Shares Climb 0.28 as Trading Volume Slumps 25.16 Percent to $370M Ranked 243rd in Market Activity

On August 18, 2025, Humana (HUM) closed with a 0.28% gain, while trading volume fell 25.16% to $0.37 billion, ranking the stock 243rd in market activity. Institutional investor activity and earnings dynamics emerged as key drivers for the healthcare insurer’s recent performance.

Prudential PLC significantly reduced its stake in HUM by 56.7% during Q1, selling 5,290 shares to retain 4,042 shares valued at $1.07 million. Conversely, Vanguard Group Inc. increased its position by 8.9%, now holding 13.97 million shares worth $3.697 billion. GAMMA Investing LLC’s dramatic 40,881.1% rise in ownership highlights renewed institutional confidence, with the firm acquiring 781,099 shares valued at $2.067 billion.

Earnings revisions and analyst activity further shaped the stock’s trajectory. HUM reported Q2 earnings of $6.27 per share, below estimates, but revenue grew 9.6% year-over-year to $32.39 billion. Analysts revised 2025 earnings estimates upward by $0.62 to $16.99 per share, while Raymond James Financial upgraded its rating to "outperform" with a $315 price target. However, Wall Street Zen cut its stance to "hold," reflecting mixed sentiment. The stock currently carries a Zacks Momentum Style Score of B and an average analyst rating of "Hold."

A strategy based on trading volume showed limited effectiveness: purchasing top 500 volume stocks daily and holding for one day generated a $2,340 profit from 2022 to 2025, yielding a 23.4% cumulative return. This suggests volume-driven approaches remain cautiously neutral for HUM amid its recent institutional activity and earnings adjustments.